For Research Use Only. Not for use in diagnostic procedures.
Advanced Fluorescence Imaging for Rare Cell Detection
Integrated optical systems and artificial intelligence driven algorithms designed for research and translational applications.
A New Approach for Rare Cell Detection
Engineered for What Others Can't Find
Axon Dx develops fluorescence imaging platforms engineered to detect and analyze rare cellular events within complex biological samples. Our systems integrate precision optics, automated slide scanning, and algorithm-assisted image analysis into cohesive research platforms designed to support high-sensitivity cellular detection.
Multi-Channel Fluorescence Imaging
High-resolution multi-spectral fluorescence imaging with automated whole-slide scanning and structured data archiving for reproducible rare-cell analysis.
AI-Assisted Cellular Identification
Artificial intelligence driven algorithms identify and classify rare cells — CTCs, CSCs, TILs, and circulating endothelial cells — with precision across complex biological matrices.
nCyte™ Platform
AXON Dx's nCyte™ technology scans un-enriched blood samples in minutes, finds all classes of rare cells shed by solid tumors, and offers morphological, proteomic, and genomic characterization of positive cells.
1 in 10⁷
Circulating tumor cells are present among nearly 10 million nucleated blood cells per mL of whole blood.
Finding them changes everything.
Precision Engineering
Built for the Most Demanding Research
Our instruments are engineered to operate at the intersection of optical physics, microfluidics, and computational biology — delivering reproducible results in the most complex biological environments.
Ready to Advance Your Research?
Axon Dx is dedicated to providing research tools that make hunting for rare cells, such as circulating tumor cells or circulating endothelial cells, a simple diagnostic test.